Comparison of estrogen responsive genes in the mouse uterus, vagina and mammary gland.
Female reproductive organs are mainly regulated by estrogen and progesterone. Specifically, the uterus, vagina and mammary gland show organ-specific mitosis and morphological changes during proliferative events, such as estrous cycle, gestation and lactation. The mechanism underlying these organ-specific estrogen-dependent events is still unknown. We examined, therefore, global gene expression in the mature uterus, vagina and mammary gland of ovariectomized adult mice 6 hr after an injection of 5 microg/kg 17beta-estradiol (E2) using a microarray method in order to identify primary E2-responsive genes. Half of the E2 up-regulated genes in the uterus were similar to those in the vagina. E2 up-regulated the expression of Insulin-like growth factor 1 (Igf-1) genes in the uterus and vagina. In the vagina, E2 up-regulated the expression of IGF binding proteins (Igfbp2 and Igfbp5). In the mammary gland, unlike the uterus and vagina, no gene showed altered expression 6 hr after the E2 exposure. These results suggest that expression of Igf-1 and morphogenesis genes is regulated by E2 in an organ-specific manner, and it is supported by the results of BrdU labeling showing E2-induced mitosis in the uterus and vagina except the mammary gland. The differences in organ specificity in response to E2 may be attributed by differences in gene expression regulated by E2 in female reproductive organs. The candidate estrogen-responsive genes in the uterus and vagina identified by profiling provide an important foundation understanding functional mechanisms of estrogen regulating morphogenesis and maintenance of each reproductive organ.
The United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida 753-8515, Japan.
Atsuko
A
Suzuki
Hiroshi
H
Urushitani
Hajime
H
Watanabe
Tomomi
T
Sato
Taisen
T
Iguchi
Tomohiro
T
Kobayashi
Yasuhiko
Y
Ohta
D000818:Animals; D001973:Bromodeoxyuridine / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects*; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000096:biosynthesis / Q000235:genetics; D018975:Insulin-Like Growth Factor Binding Protein 5 / Q000096:biosynthesis / Q000235:genetics; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis / Q000235:genetics; D008321:Mammary Glands, Animal / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D051379:Mice; D020411:Oligonucleotide Array Sequence Analysis; D010052:Ovariectomy; D020840:Tissue Kallikreins / Q000096:biosynthesis / Q000235:genetics; D014599:Uterus / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D014621:Vagina / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*
D018970:Insulin-Like Growth Factor Binding Protein 1; D018975:Insulin-Like Growth Factor Binding Protein 5; D004958:Estradiol; D007334:Insulin-Like Growth Factor I; D020840:Tissue Kallikreins; D001973:Bromodeoxyuridine